Brussels, 05/05/2010 (Agence Europe) - On Wednesday 5 May, the European Commission sent a reasoned opinion to Germany for incorrectly applying EU rules on well established medicinal use when authorising medicinal products pursuant to Directive 2001/83/EC. EU law foresees a simplified authorisation procedure for medicinal products containing an active substance that has been extensively used for at least a decade in the European Union and is therefore considered to have a proven track record...